Bobak R. Azamian

President/CEO and Board Chair

Bobak R. Azamian (President/CEO and Board Chair) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales, 1 filed past the two-business-day deadline), most often in Tarsus Pharmaceuticals, Inc. (TARS). The largest single filing was $2.4M of TARS (34,603 sh across 3 lots, as filed), executed Mar 17.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 6 sells · 1 late

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$5.1M

shares × price, as filed

Last traded

Sep 4

Filed Sep 9

Median ADV $68.4M across their filed names

Open performance→

Volume by month

Buys $0 Sells $7.2M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 6 filings

Sector per market data · by filing · past 12 months

Most traded names

TARS

Tarsus Pharmaceuticals, Inc. TARS · 0 buys · 9 sells 9 filings

Recent filings

TARSSALE Tarsus Pharmaceuticals, Inc. View filing → $906K
10,000 sh across 2 lots
Exec Sep 4
Filed Sep 9 · 4:14 PM ET TARSSALE Tarsus Pharmaceuticals, Inc. View filing → $801K
10,000 sh × $80.06
Exec Sep 2
Filed Sep 3 · 4:30 PM ET TARSSALE Tarsus Pharmaceuticals, Inc. View filing → $615K
10,000 sh across 2 lots
Exec Jun 17
Filed Jun 22 · 5:30 PM ET TARSSALE Tarsus Pharmaceuticals, Inc. View filing → $2.4M
34,603 sh across 3 lots
Exec Mar 17
Filed Mar 19 · 5:30 PM ET TARSSALE Tarsus Pharmaceuticals, Inc. View filing → $449K
5,443 sh × $82.41
Exec Dec 24 2025
Filed Dec 30 2025 · 5:30 PM ET † TARSSALE Tarsus Pharmaceuticals, Inc. View filing → $332K
6,000 sh × $55.37
Exec Sep 24 2025
Filed Sep 26 2025 · 5:30 PM ET TARSSALE Tarsus Pharmaceuticals, Inc. View filing → $300K
6,000 sh × $50.00
Exec Aug 11 2025
Filed Aug 13 2025 · 5:30 PM ET TARSSALE Tarsus Pharmaceuticals, Inc. View filing → $300K
6,000 sh × $50.00
Exec Mar 24 2025
Filed Mar 26 2025 · 5:30 PM ET More filings →